Table 4. Postoperative events.
| Character | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case7 | Case 8 | Case 9 | Case 10 | Case11 | Case12 | Case 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morbidity | – | – | – | – | – | – | – | – | – | – | Pneumonia | – | – |
| Postoperative hospital stay (d) | 7 | 10 | 12 | 8 | 7 | 15 | 8 | 9 | 7 | 13 | 20 | 12 | 9 |
| ICU stay (d) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Duration of thoracic drainage (d) | 3 | 6 | 6 | 5 | 3 | 8 | 5 | 4 | 5 | 6 | 5 | 4 | 2 |
| Thoracic drainage (mL) | 700 | 1500 | 1,500 | 1,330 | 835 | 1,700 | 950 | 1,100 | 850 | 680 | 700 | NA | NA |
| Adjuvant chemotherapy | TXT/TO | TXT/LOP | PAX/.LOP | PAX/DDP | PAX/LOP | – | PAX/DDP | PAX/DDP | – | – | – | VP-16/DDP | – |
| Chemotherapy cycles | 4 | 4 | 4 | 4 | 4 | – | 4 | 4 | On | On | – | 4 | On |
| Follow-up duration (month) | 26 | 15 | 9 | 7 | 4 | 3 | 3 | 3 | 2 | <1 | 3 | 6 | 1 |
| Status | Live | Live | Live | Live | Live | Live | Live | Live | Live | Live | Live | Live | Live |
TXT, docetaxe; TO, oxaliplatin; LOP, lobaplatin; PAX, paclitaxel; DDP, cisplatin; VP-16, etoposide; NA, no available.